Caduet enhances connexin 43 phosphorylation in left ventricular and thoracic aorta of SH model rats

Xiaoyan Huang1, Junlu Yang2, Baoguo Song3

  • 1Shaanxi Provincial Key Laboratory of Infection and Immunity Diseases, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, P.R. China.

Insights

Caduet (amlodipine and atorvastatin) improves cardiac and vascular remodeling in spontaneous hypertension by enhancing connexin 43 phosphorylation. This combination therapy shows superior efficacy compared to individual components in reducing hypertensive remodeling.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Molecular Biology

Background:

  • Spontaneous hypertension (SH) leads to cardiac and vascular remodeling.
  • The mechanism by which Caduet (amlodipine besylate and atorvastatin calcium) improves SH remodeling is not fully understood.
  • Connexin 43 (Cx43) phosphorylation is implicated in cardiovascular remodeling.

Purpose of the Study:

  • To investigate if amlodipine and atorvastatin (AM + AT) improve hypertensive left ventricular and thoracic aortic remodeling by regulating Cx43 phosphorylation.
  • To compare the efficacy of combined AM + AT therapy with individual components in SH rats.

Main Methods:

  • Spontaneous hypertension model rats (SHR) and Wistar-Kyoto (WKY) rats were used.
  • Rats were treated with control, amlodipine alone, atorvastatin alone, or AM + AT for 8 weeks.
  • Left ventricular mass index (LVMI), blood pressure, lipid levels, and Cx43 (total and phosphorylated) expression in cardiac and aortic tissues were analyzed.

Main Results:

  • AM + AT significantly decreased LVMI and cardiomyocyte size compared to single-drug groups.
  • AM + AT inhibited total Cx43 (T-Cx43) and increased phosphorylated Cx43 (P-Cx43) in the left ventricle and thoracic aorta.
  • Immunofluorescence confirmed decreased T-Cx43 and increased P-Cx43 with AM + AT treatment.

Conclusions:

  • AM + AT may mitigate left ventricular and thoracic aorta remodeling in SH rats by enhancing Cx43 phosphorylation.
  • Combined AM + AT therapy demonstrates superior efficacy over amlodipine or atorvastatin alone in this model.

Related Concept Videos